Shriram Finance Regulatory Approval

Debt & Borrowing

Shriram Finance Debt & Borrowing: ₹10.72 Cr

Shriram Finance confirmed timely payment of ₹10.72 Crore interest on NCDs (ISIN INE721A07SP0). Routine debt-servicing certification under Reg 57.

Value

₹10.72 Cr

Debt & Borrowing

Shriram Finance Debt & Borrowing: ₹60.03 Cr

Shriram Finance paid Rs 4,121.60 lakh and Rs 1,881.25 lakh interest on NCDs and subordinated debt. Routine debt servicing with no new capital raised.

Value

₹60.03 Cr

Other Announcement

Shriram Finance Other Announcement

Shriram Finance filed CRISIL's quarterly monitoring report on preferential issue proceeds for Q2 FY27. Proceeds were utilized towards onward lending with no deviation from objects.

Earnings Call

Shriram Finance Earnings Call Transcript: Key Takeaways

Shriram Finance delivered strong profit growth despite seasonal headwinds, though asset quality in drought-prone regions saw a temporary uptick. Management maintains a cautious but optimistic outlook for the busy second half.

Call

Guides 17% growth

Management Change

Shriram Finance Management Change

Shriram Finance appointed Panakala Raju M as Chief Software Officer, effective October 23, 2026. The appointment was approved at the board meeting held the same day.

Dividend

Shriram Finance Dividend

Shriram Finance fixed October 29, 2026 as the record date for its FY2026-27 interim dividend. Payment will be made to eligible members before November 20, 2026.

Regulatory ApprovalShalby Ltd SHALBYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Shalby Regulatory Approval

Shalby Hospital, Jabalpur received CMHO permission to resume normal operations, including patient admissions, on its previously affected floor. The hospital has now fully resumed healthcare services.

Regulatory ApprovalElantas Beck India Ltd ELANTASAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Elantas Beck India Regulatory Approval

Elantas Beck India's GPCB permanently revoked the closure direction on its Ankleshwar plant. The facility can keep operating, subject to compliance conditions.

Regulatory ApprovalKalyani Cast-Tech Ltd 544023Alfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Kalyani Cast-Tech Regulatory Approval

Kalyani Cast-Tech received RDSO Stage-I concept design approval for its new container-carrying wagon under PWDA. Stage-II detailed design approval is still required, subject to dynamics simulation conditions.

Regulatory ApprovalMukka Proteins Ltd MUKKAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution

October 1, 2026 to December 31, 2027

Regulatory ApprovalCanara Bank CANBKAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Canara Bank Regulatory Approval

Canara Bank received RBI permission to exercise the call option on its Basel III AT1 bonds (ISIN INE476A08134) of Rs.1,500 Crore. The bank is now in process of exercising the call as per the issue terms.

Value

₹1,500 Cr

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for Valganciclovir for Oral Solution, 50 mg/mL. This adds to its cumulative 247 USFDA ANDA approvals.